期刊文献+

高敏C反应蛋白及白细胞介素6在心房颤动并发血栓中的意义 被引量:4

Relationship of high-sensitive C-reactive protein,IL-6 and atrial fibrillation combining with thrombosis
原文传递
导出
摘要 目的:探讨心房颤动(房颤)患者血浆高敏C-反应蛋白(hs-CRP)、白细胞介素6(IL-6)与左房内血栓形成的关系。方法:根据心脏超声检查结果将148例房颤患者分为血栓组(56例)和非血栓组(92例),分别测定两组血浆hs-CRP和IL-6浓度,同时测定左房内径及左室射血分数(LVEF),分析hs-CRP、IL-6与血栓形成的关系。结果:血栓组血浆hs-CRP与IL-6浓度均明显高于非血栓组[(4.38±0.56)g/L∶(1.12±0.27)g/L,(156.6±29.4)ng/L∶(114.5±20.7)ng/L;均P<0.05];Logistic回归发现,高hs-CRP(OR=2.631)、高IL-6(OR=2.965)及左房内径扩大(OR=4.337)是血栓形成的独立危险因素(均P<0.05)。结论:hs-CRP及IL-6升高、左房扩大是房颤患者左房血栓形成的独立危险因素,炎症反应在房颤心房血栓形成过程中可能起重要作用。 Objective: To investigate the alteration of plasma high sensitive C-reactive protein (hs CRP) and interleukin-6 (IL-6) in patients with atrial fibrillation combining thrombosis. Method.. Patients with atrial fibrillation were divided into thrombus group (n: 56) and non-thrombus group (n= 92) according to echocardiography results. The plasma hs-CRP and IL-6 concentrations and LVEF values as well as [eft atrium diameter were measured. Logistic multi-factors regression analysis was performed. Result: Plasma hs-CRP and IL-6 concentrations in thrombus group were significantly higher than those in non-thrombus group [(4.38 ± 0. 56)g/L : (1.12±0.27)g/L, ( 156.6 ± 29.4) ng/L : ( 114.5 ± 20.7) ng/L; both P 〈 0.05 ]. Logistic multi-factors regression analysis showed that high plasma concentrations of hs CRP (OR: 2. 631), IL-6 (OR: 2. 965) and enlarged left atrium diameter (OR= 4. 337) were main independent risk factors of patients with atrial fibrillation combining thrombosis (all P〈 0.05). Conclusion.. hs-CRP and IL-6 were independent risk factors of patients with atrial fibrillation combining thrombosis. Inflammatory reaction may play an important role in the formation of thrombosis in patients with atrial fibrillation.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第3期171-173,共3页 Journal of Clinical Cardiology
关键词 心房颤动 高敏C-反应蛋白 白细胞介素6 血栓形成 atrial fibrillation high-sensitive C-reactive protein interleukin-6 thrombosis
  • 相关文献

参考文献10

  • 1TSIOUFIS C, SYRSELOUDIS D, HATZIYIANNI A, et al. Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects[J]. Am J Hypertens,2010,23:202-207.
  • 2KALI.ERGIS E M, MANIOS E G, KANOUPAKIS E M, et al. The role of the post-cardioversion time course of hs CRP levels in clarifying the relationship between inflammation and persistence of atrial fibril- lation[J]. Heart, 2008,94 : 200 - 204.
  • 3ZHAO Q, ZHANG S, HUANG H, et al. Inflamma- tion abnormalities and inducibility of atrial fibrillation after epicardial ganglionated plexi ablation[J]. Arch Cardiovasc Dis, 2011,104 : 227 - 233.
  • 4SCHOOS M M, KELBAK H, KOFOED K F, et al. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarc- tion, and stent thrombosis according to stent type in patients with ST segment elevation myocardial infarc- tion randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention [J]. AmJ Cardiol,2011,107:1597-1603.
  • 5JEZOVNIK M K, POREDOS P. Idiopathic venous thrombosis is related to systemic inflammatory re- sponse and to increased levels of circulating markers of endothelial dysfunction[J]. Int Angiol, 2010,29: 226-231.
  • 6CORRADO E, RIZZO M, COPPOLA G, et al. An up- date on the role of markers of inflammation in atheroscle-rosis[J]. J Atheroscler Thromb, 2010,17 : 1- 11.
  • 7LUXEMBOURG B, SCHMITT J, HUMPICH M, et al. Cardiovascular riskfactors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor active protein (hs-CR 102:668-675. VIII, and high-sensitivity C-re- P)[J]. Thromb Haemost,2009,.
  • 8罗助荣,张克己,林毅,郑磊磊,徐高阳,盖晓波.ACS血清OPG、sRANKL与hs-CRP及冠状动脉病变程度的相关性研究[J].临床心血管病杂志,2011,27(7):499-502. 被引量:9
  • 9SEN A, PAINE S K, CHOWDHURY I H, et al. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease[J]. Mol Vis,2011,17:2552-2563.
  • 10陈克俭,刘凯,胡丽丽.阿托伐他汀对非ST段抬高型心肌梗死患者血清炎性因子水平影响[J].临床心血管病杂志,2012,28(1):46-48. 被引量:7

二级参考文献17

  • 1ZHANG Xing-wei,GE Jun-bo,YANG Jian-min,GE Lei,WANG Ning-fu,GAO Yan,LI Pei-zhang,PAN Hao,TONG Guo-xin,ZHOU Liang,YE Xian-hua,XU Jian.Relationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study[J].Chinese Medical Journal,2006(20):1689-1694. 被引量:23
  • 2LIBBY P. Molecular bases of the acute coronary syndromes[J]. Circulation,1995,91:2844-2850.
  • 3YASUDA H, SHIMA N, NAKAGAWA N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J]. PNAS, 1998,95 : 3597-3602.
  • 4KIECHL S, SCHETT G, WENNING G, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease[J]. Circulation, 2004,109 : 2175-2180.
  • 5JONO S, SHIOI A, IKARI Y, et al. Vascular calcifi cation in chronic kidney disease (Rev)[J]. J Bone Miner Metab, 2006,24 :176 -181.
  • 6SHUICHI J, YUJI I, ATSUSHI S, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease[J]. Circulation, 2002,9 : 1192-1194.
  • 7CRISAFULLI A, MICARI A, ALTAVILLA D, et al. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction[J]. Clin Science,2005,109:389-395.
  • 8SCHOPPET M, SCHAEFER J R, HOFBAUER L C, et al. Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men[J]. Circulation, 2003,107 : e76-76.
  • 9LIBBY P. Inflammation in atherosclerosis[J]. Nature,2002,420:868-87.
  • 10HANSSON G K, LIBBY P, SCHONBECK U, et aI. Innate and adaptive immunity in the pathogenesis of atheroselerosis[J]. Circ Res, 2002,91 : 281 -291.

共引文献14

同被引文献42

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部